ISSN : 2287-6618(Online)
DOI : https://doi.org/10.11620/IJOB.2013.38.3.087
Quantification of Microstructures in Mice Alveolar Bone using Micro-computed tomography (μCT)
Abstract
- 13-15R1.pdf456.7KB
Introduction
A common inflammatory oral disease involves periodontal disease and periodontal tissue linked with a systemic disorder. Bacteria are important causes of bone pathology in common conditions such as periodontitis and dental cysts [1]. Periodontal disease increases the risk of tooth loss, particularly in cases with an associated loss of alveolar bone and periodontal ligament (PDL) [2]. Periodontal inflammation is represented by the loss of supporting connective tissue and alveolar bone around the teeth [3]. Bacterial infections produce destruction of the periodontal tissue caused by the inflammatory response to the pathogenic bacteria. Immune mediators such as interleukin-1 (IL-1), tumor necrosis factor alpha (TNF-α), and IL-6 have been found to be abundantly expressed in periodontal disease [4]. Periodontal diseases are a group of infections that lead to inflammation of the gingiva, destruction of the periodontal tissues, and, in severe cases, loss of alveolar bone with eventual exfoliation of the teeth [5]. The inflammation induces detachment of the periodontal ligament, with loosening of the connection between the gingiva and alveolar bone, allowing the extension of the oral bacterial infection [6]. Periodontal disease has been suspected as a trigger of systemic disorders. Penetration of bacterial products, such as lipopolysaccharide (LPS) may reach into deeper periodontal tissues. This may affect the systemic blood circulation and cytokine production [7]. Interleukin-1β (IL-1β) shows a significantly increased production of low dose LPS groups but TNF-α does not show a significant increase in production [8]. The cytokine dysregulation associated with prolonged TNF-α expression represents a mechanism through which bacteria may induce a more damaging inflammatory disease [9]. Lipopolysaccharides (LPS) of gramnegative bacteria were potent inducers of pro-inflammatory mediators and could initiate numerous host-mediated destructive processes [10,11].
Micro-computed tomograpy (Micro-CT) offers significant potential for identifying microstructures [12,13]. Micro-CT for preclinical applications provides higher spatial resolution images than medical or dental CT for clinical assessment.
To achieve three-dimensional evaluation of alveolar bone loss in periodontitis animal models, micro-computed tomography(micro-CT) has been used in recent studies [14,15]. This study was investigated the effects of alveolar bone loss in E. coli LPS and TNF-α on E. coli LPS-induced mice evaluated by micro-CT. And also this method suggested that the periodontal ligament and interdental alveolar process space length could be quantified using the micro-CT. Our findings offer a TNF-α on LPS-induced mice model to study the role of inflammatory processes and the degree as quantified by micro-CT. This study was done to assess periodontal tissue breakdown after E. coli LPS and TNF-α on LPS-induced experimental periodontitis in mice and the use of micro-CT as a rapid quantification method for alveolar bone and PDL loss assessment.
Materials & Methods
Animals model preparation
BALB/c 8-week-old female mice were randomly divided into 3 groups (n = 10 per each groups). All animals were housed at standard temperature and humidity with a 12-h light/dark cycle, and their body weights were recorded before the test procedures. The mice were fed with standard rodent chow and water ad libitum. The experimental protocols were approved by the Chonnam National University Institutional Animal Care and Use Committee. The mice (20 g per each) had experimental periodontitis induced in the interdental region between the mandible first (M1), second (M2) and third molars (M3).
Inflammatory Bone Loss Model
The bone loss model was generated as previously described [16]. To initiate alveolar bone loss, micro-injections of 10 mg/kg E. coli LPS (20 μg per injection in 2 μl PBS total volume, Sigma, MO, USA) were made directly into the palatal interproximal gingiva between the first and second molars on the left side. The same volume of PBS was injected into the same region on the right side [17]. E. coli LPS and PBS injections were repeated 3 times each week over 10 weeks (denoted by LPS and PBS). The E. coli LPS treated side was injected with TNF-α (PeproTech, seoul, Korea) (denoted by TNF/LPS). Oral injections of 100 μg/kg of TNF-α were repeated two times per week over a 10 week period.
Micro-CT and Bone Volume Fraction (BVF) Analysis
Micro-CT analysis was performed as previously described [18]. Briefly, after euthanasia, the molar with intact surrounding tissue from each animal was dissected and fixed in freshly prepared 4% paraformaldehyde (pH 7.2) at 4°C overnight for scanning by Micro-CT. Specimens were scanned by Skyscan 1172 Desk Top micro-CT. The system used was Scanner of Skyscan1172, Instrument S/N=054, Hardware version of A, software of Version 1. 5. Analysis with GE microview software (Microview Software Technologies, USA) was done for quantification of the bone volume fraction (BVF). Loss of bone volume was assessed by means of 3-D displays as previously described [19]. Briefly, given a series of projection images, a stack of 2D sections was reconstructed for each specimen (the number of sections depended on the desired height) and stored in the bmp format condition. In each scan, a standardized tridimensional region of interest (ROI) was defined by the following landmarks: first molar (M1), second molar (M2) and third molar (M3).
Statistics
Data were expressed as the mean±SD from three independent triplicate experiments. Statistical analysis was performed by one-way analysis of variance (ANOVA) followed by the Student’s t-test. For all analyses, p<0.05 was considered statistically significant.
Results
The effects of oral administration of E. coli LPS and TNF-α on food intake and body weight was assessed. The mice were given an oral injection with 10 mg/kg of E. coli LPS repeated 3 times each week over 10 weeks. The mice were orally injected with 10 mg/kg of E. coli LPS with the addition of 10 μg/kg of TNF-α repeated two times per week over a 10 week period. The control mice were treated with PBS over the same period. The effects of E. coli LPS and TNF-α/E. coli LPS on food intake and body weight were checked time dependently for 20 weeks. The food intake of the TNF/LPS mice was decreased compared with that of the PBS and LPS mice in a time dependent manner (Fig. 1A). The body weight of the LPS and TNF/LPS mice was decreased more than the body weight of the PBS mice (Fig. 1B).
Fig. 1. The daily food uptake and body weight of mice. A daily food intake (g/day) was checked in PBS, LPS and TNF/ LPS mice (A). Body weight changes were monitored in PBS, LPS and TNF/LPS mice until 20 weeks (B). Numbers of animals studied were 10 in each group.
Two-dimensional (2D) serial sections showed all the mandibular molar teeth extracted from the mice. Alveolar bone loss was estimated by measuring the length of the periodontal ligament and interdental alveolar process space in the 2D reconstruction images. Transverse serial sections(0.5 mm) images with the corresponding micro-CT marked off the first molar (M1), second molar (M2) and third molar (M3). The length of the periodontal ligament in the LPS and TNF/LPS showed an increase compared with PBS (Fig. 2A). Quantification of the periodontal ligament length revealed statistically significant increases in LPS and TNF/LPS compared with PBS (Fig. 2B). The interdental alveolar process space length in the LPS and TNF/LPS was greater than in PBS (Fig. 3A). Quantification of the alveolar process space length revealed statistically significant increases in LPS and TNF/LPS compared with PBS (Fig. 3B). There was no difference between LPS and TNF/LPS in the length of the periodontal ligament and interdental alveolar process space. There was no difference in alveolar bone loss between TNF-α and TNF-α in the E. coli LPS mice. The alveolar bone loss was represented as the length of the periodontal ligament and interdental alveolar process space using 2D- and 3D measurements. The treatment with 10 mg/kg of E. coli LPS and 100 μg/kg of TNF-α caused destruction of the periodontal ligament and alveolar process space. The lengths of the periodontal ligament and alveolar process space were more affected by 100 μg/kg of TNF-α (TNF/ LPS) in 10 mg/kg of E. coli LPS-induced on mice.
Fig. 2. Effects of LPS and TNF/LPS on periodontal ligament length. The 2D displayed periodontal ligament length at PBS, LPS and TNF/LPS mice (A). Comparison of the relative bone loss indicated that the periodontal ligament length in LPS and TNF/LPS mice was significantly greater than that in PBS mice (B). The indicated white bar was 0.5 mm. The white bar was the distance of the periodontal ligament length. *indicates a significant difference, p < 0.05.
Fig. 3. Effects of LPS and TNF/LPS on the interdental alveolar process space. The 2D displayed the length of the alveolar process space loss at PBS, LPS and TNF/LPS mice (A). Comparison of the relative bone loss indicated that the alveolar process space length in LPS and TNF/LPS mice was significantly greater than that in PBS mice (B). The indicated red bar was 1 mm. The red bar was the distance of the alveolar process space. *indicates a significant difference, p < 0.05.
Volumetric micro-CT measurements were three dimensional (3D) structures in the periodontal ligament and alveolar process space. 3D reconstruction of the mandibular bone showed the lingual surface at the alveolar bone. Analysis of the alveolar bone including all three molars can be done by using the method for creating 3D ROIs. TNF/ LPS showed reduction of the alveolar bone process (Fig. 4). 3D micro-CT measurements showed the alveolar bone loss in LPS and TNF/ LPS compared with PBS.
Fig. 4. LPS and TNF/LPS treated mice demonstrated significantly decreased alveolar bone volume fraction (BVF) in comparison with PBS. The 3D representative specimens displayed the periodontal ligament and alveolar process space. TNF or TNF/LPS mice demonstrated a decreased alveolar bone volume fraction (BVF) in comparirson with PBS mice. The volume of interest (VOI) was established in the micro-CT reconstruction. VOI was established with a three dimensional reconstruction displaying the periodontal ligament and alveolar bone loss in PBS, LPS and TNF/LPS mice. M1; first molar, M2; second molar and M3; third molar.
Discussion
In this study, E. coli LPS or TNF-α on E. coli LPS induced inflammation was successfully used to induce experimental periodontitis in mice. TNF-α can be induced by bacterial products and is considered as an early event in the cascade leading to inflammation [20]. Intragingival injection of 10 mg/kg of E. coli LPS has been accepted as a useful experimental model of periodontitis with alveolar bone loss. 10 weeks after, LPS injection resulted in significant gingival and periodontal inflammation with inflammatory infiltrate interdental bone loss. It indicated that intragingival injection of LPS in the rat provides an easily induced reproducible experimental model of periodontal inflammation [21]. Our results showed site-specific, alveolar bone loss, and inflammation in this model. Quantification of the periodontal ligament length and interdental alveolar process space was done using micro-CT methods. We found that the methods yielded comparable results for detecting alveolar bone loss. Moreover, the osteoclast activity observed in this study was consistent with the progression of inflammation in a monkey model [22]. Periodontal disease is the most frequent cause of tooth loss, including osteoporosis [23]. This finding was similar to the research done by Fokkema, et al. [24]. Micro-CT is a recent technology available in bone laboratories. Micro-CT has been widly used in the study of bone metabolism. Previous reports showed that micro-CT is an effective method for the histomorphometrical analysis of long bone inovariectomized rats and gene-deficient mice [25]. A 3D finite element model of a tooth with different levels of bone height was constructed to estimate the reduction [26]. The selected landmarks for quantification of alveolar bone (ROF, the most distal end of molar roots, and tangent line between roots on the coronal plane for landmark detection of ROI) provided critical criteria and reproducibility to measure volumetric osseous parameters. These approaches for the quantitative assessment of periodontal osseous structures demonstrated the reliability and reproducibility of 3-D micro-CT measurements of alveolar bone loss.
In this study, the roles of E. coli LPS or TNF-α in E. coli LPS-induced alveolar bone loss mice model were studied. But no difference between E. coli LPS and TNF-α on E. coli LPS-induced alveolar bone loss were found using micro-CT. The destroyed periodontal ligaments and alveolar process space showed the same results of alveolar bone loss. This experiment, once again, proved the contribution of periodontal disease in the pathogenesis of systemic diseases.
Further study needs to be done to investigate the close relationship between periodontal disease and systemic disease using in vivo micro-CT imaging approaches for realtime assessments of alveolar bone changes that could lead to dynamic, rather than static, measures of osseous change.
Acknowledgement
This study was supported by a grant (CRI13011-1) of the Chonnam University Hospital Research Institute of Clinical Medicine.
Reference
2.Cochran DL. Inflammation and bone loss in periodontal disease. J Periodontol. 2008;79(8 Suppl):1569-1576.
3.Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. The Lancet.2005;366(9499):1809-1820.
4.Boch JA, Wara-aswapati N, Auron PE. Interleukin 1 Signal Transduction-Current Concepts and Relevance to Periodontitis. J Dent Res. 2001; 80(2):400-407.
5.Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000;994:5:78-111.
6.Baker PJ. The role of immune responses in bone loss during periodontal disease. Microbes Infect. 2000; 2(10):1181-1192.
7.Henderson B, Poole S, Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev. 1996;60:316-341.
8.Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases Caused by Oral Infection. Clin. Microbiol. Rev. 2000;13 (4):547-558.
9.Jonarta AL, Asmara W, Astuti I, Tandelilin RTC. 1 Systemic IL-1β and TNF-α Productions of E. coli Lipopolysaccharide-Induced Periodontitis Model on Rats. The Indonesian J Dent Res. 2010;1(1):49-54.
10.Kim SR, Jeong SK, Kim WS, Jeon HJ, Park HJ, Kim MK, Jang HO, Yun I, Bae SK, Bae MK. The Lipopolysaccharide from Porphyromonas gingivalis Induces Vascular Permeability. Int J Oral Biol. 2011;36(1):23-29
11.Jain S, Darveau RP. Contribution of Porphyromonas gingivalis lipopolysachharide to periodontitis. Periodontol 2000. 2010; 54(1): 53-70.
12.Park CH, Abramson ZR, Taba M, Jr. Jin Q, Chang J, Kreider JM, Giannobile WV. Three-dimensional micro-computed tomographic imaging of alveolar bone in experimental bone loss or repair. J Periodontol. 2007;78(2):273-281.
13.Moon HS, Won YY, Kim KD, Lee SW, Baek MH, Kook HK, Chung MK. The three dimensional analysis of microstructure of Mandibular trabecular bone. Implantology. 2003;10:2312-24.
14.Naito T, Hosokawa R, Yokota M. Three-dimensional alveolar bone morphology analysis using computed tomography. J Periodontol 1998;69:584-589.
15.Wilensky A, Gabet Y, Yumoto H, Houri-Haddad Y, Shapira L. Three-dimensional quantification of alveolar bone loss in Porphyromonas gingivalis-infected mice using microcomputed tomography. J Periodontol. 2005;76:1282-1286.
16.Sartori R, Li F, and Kirkwood KL. MAP Kinase Phosphatase-1 Protects against Inflammatory Bone Loss. J Dent Res. 2009;88(12):1125-1130.
17.Rogers JE, Li F, Coatney DD, Rossa C, Bronson P, Krieder JM. Actinobacillus actinomycetemcomitans lipopolysaccharidemediated experimental bone loss model for aggressive periodontitis. J Periodontol. 2007;78:550-558.
18.Park HR, Park BJ. Micro-CT analysis of LPS-induced Alveolar Bone Loss in Diabetic Mice. Int J Oral Biol. 2012;37(3): 85-90.
19.Kirkwood KL, Li F, Rogers JE, Otremba J, Coatney DD, Kreider JM. A p38alpha selective mitogen-activated protein kinase inhibitor prevents periodontal bone loss. J Pharmacol Exp Ther. 2007;320:56-63.
20.Teng YTA, Nguyen H, Gao X, Kong XX, Gorczynski RM, Singh B, Ellen RP, Penninger JM. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J.Clin.Invest. 2000;106(6):R59-67.
21.Miyauchi M, Sato S, Kitagawa S, Hiraoka M, KudoY, Ogawa I, Zhao M, Takata T. Cytokine expression in rat molar gingival periodontal tissues after topical application of lipopolysaccharide. Histochem Cell Biol. 2001;116: 57-62.
22.Graves DT, Delima AJ, Assuma R, Amar S, Oates T, Cochran D. Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis. J Periodontol. 1998;69:1419-1425.
23.Marques MR, Silva MAD, Barros SP. Periodontal disease and osteoporosis association and mechanisms: A review of the literature. Braz J Oral Sci. 2003;2(4):137-140.
24.Fokkema S, Loos B, Slegte C, Van Der Velden U. A type 2 response in lipopolysaccharide (LPS)-stimulated whole blood cell cultures from periodontitis patients. Clin Exp Immunol. 2002;127:374-378.
25.Peterkofsky A, Wang G, Garrett DS, Lee BR, Seok YJ, Clore GM. Three-dimensional structures of protein-protein complexes in the E. coli PTS. J Mol Microbiol Biotechnol. 2001; 3(3):347-354.
26.Ishijima MTK, Rittling SR, Yamashita T, Kurosawa H, Denhardt DT, Nifuji A, Noda M. Resistance to unloadinginduced three-dimensional bone loss in osteopontin-deficient mice. J Bone Miner Res. 2002;17:661-667.